LYMPHIR™ Launch: AI-Powered Oncology Treatment Advances

Citius Oncology Accelerates LYMPHIR™ Launch with Verix AI Integration Citius Oncology (Nasdaq: CTOR) is poised to revolutionize treatment for Cutaneous T-Cell Lymphoma (CTCL) with the impending commercial launch of LYMPHIR™, now significantly bolstered by a strategic integration with Verix AI. This collaboration, announced today, aims to optimize the identification of suitable patients and streamline the … Read more

DC Shutdown & Stock Market: What’s Next?

Stock Market Defies Washington Impasse: Why Investors Remain Optimistic Despite a partial U.S. government shutdown entering its second week, stock markets have demonstrated surprising resilience, continuing to climb and even reach new highs. This apparent disconnect between political turmoil in Washington and Wall Street’s performance has left many wondering about the underlying factors driving investor … Read more